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Ethnopharmacological relevance: Pterodon pubescens Benth is a medicinal plant commonly used for
therapeutic purposes in folk medicine for rheumatic diseases’ treatment. In the present work we
analyzed the chemical composition of the oleaginous extract of P. pubescens Benth (OEPp) and extended
the antinociceptive effect of OEPp evaluating its role on animal models of acute and chronic pain.
Materials and methods: The antinociceptive and antiedematogenic effects of OEPp (3–100 mg/kg, i.g.)
were evaluated in the formalin test; mechanical allodynia in the postoperative pain and complex
regional pain syndrome type-I (CRPS-I) animal models; and thermal hyperalgesia was induced by
plantar incision. Finally, we performed a phytochemical analysis of OEPp.
Results: The chemical composition of OEPp was analyzed by mass spectrometry (GC/MS) and eight
sesquiterpene compounds were identiﬁed, i.e. three major sesquiterpene (E-carioﬁlene, g-muurolene,
biciclogermacrene), and nine vouacapane diterpenes, four of which showed in major concentration (6a-
acetoxyvouacapane, 6a,7b-dimetoxivouacapan-17-ene, 6a-acetoxy,7b-hidroxyvouacapane, 6a,7b-dia-
cetoxycouacapane). Furthermore, the results of the present study demonstrate, for the ﬁrst time, that
the OEPp reduced mechanical allodynia in the postoperative pain and CRPS-I animal models. OEPp also
increased the paw withdrawal latency in hot- and cold-plate tests in the postoperative pain model. In
addition, the present work conﬁrms and extends previous data from literature showing that systemic
administration of OEPp caused signiﬁcant inhibition against both phases of pain response to formalin
intraplantar injection and edema formation.
Conclusions: Together, present and previous ﬁndings show that OEPp given intra-gastrically caused
signiﬁcant inhibition against both phases of formalin intraplantar injection and effectively inhibited
mechanical and thermal hyperalgesia in the postoperative pain and CRPS-I animal models.
& 2012 Elsevier Ireland Ltd.Open access under the Elsevier OA license.1. Introduction
It is estimated that the economic burden of treating chronic pain
that develops from acute pain in a 30 year-old individual, over a life
time, could be as much as $1 million (Cousins et al., 2000). The
prevention and effective relief of acute pain may improve clinical
outcomes, save health care resources and improve quality of life.
Surgical incision in postoperative patients leads to mechanical
hyperalgesia, therefore, mechanical evoked pain after surgery is
important for postoperative pain, and the underlying mechanismsax: þ55 48 3721 9672.
D.F. Martins).
der the Elsevier OA license.must be studied to improve postoperative analgesia and the out-
come of patients after surgery (Pogatzki and Raja, 2003).
Chronic post-ischemic pain (CPIP) is an animal model of
complex regional pain syndrome type I (CRPS-I). Clinically, CRPS
can begin after an injury, usually in the extremities. This trauma
may be a distal fracture, nerve lesion, post-surgical injury and
others. The syndrome is divided into two types: with major nerve
injury (type II) or without (type I) (Feliu and Edwards, 2010).
Studies in rats show that hind paw ischemia and reperfusion (IR)
causes microvascular injury (Coderre and Bennett, 2010) and
symptoms that are similar to CRPS-I in humans. These ﬁndings
reinforce the evidence that CRPS-I may depend, in part, on tissue
ischemia (Coderre et al., 2004) in patients with microvascular
pathologies that lead to chronic tissue inﬂammation (Laferriere
et al., 2008).
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and have proved to be a rich source of new active compounds,
especially to treat pain and inﬂammatory processes (Calixto et al.,
2004). The medicinal plant Pterodon pubescens Benth is popularly
known as ‘‘sucupira-branca’’ or ‘‘faveira’’ because its fruits form
small ‘‘honeycombs’’ where its essential oil is stored. It is a native
tree specie widely distributed throughout central Brazil (Lorenzi,
1998). This vegetal specie is used for therapeutic purposes, in folk
medicine, for rheumatic diseases’ treatment (Carvalho, 2004).
It has been demonstrated that the hydroalcoholic extract of
P. pubescens seeds (HEPp), administered orally, effectively inhibits
edema and pain caused by collagen-induced arthritis (Sabino
et al. 1999). Furthermore, Pinto Coelho et al. (2001) have demon-
strated that the oral administration of HEPp reduced the arthritic
index when compared to control group and concluded that HEPp
presents antiarthritic activity, with no toxic effect in mice. Here,
we examined: (i) the chemical composition of OEPp; (ii) the
possible antihyperalgesic effect of OEPp in standard rodent
models of acute and chronic pain, i.e., the intraplantar injection
of formalin, postoperative pain-induced by plantar incision sur-
gery (PIS), and chronic post-ischemic pain-induced by prolonged
hind paw ischemia and reperfusion.2. Material and Methods
2.1. Animals
All animal care and experimental procedures were carried out
in accordance with the National Institutes of Health Animal Care
Guidelines (NIH publications no. 80–23), and were approved by
the Ethics Committee of the Universidade do Sul de Santa
Catarina (protocol number 11.008.4.06.IV). Experiments were
conducted using Swiss male mice (25–35 g), obtained from the
Biote´rio Central da Universidade do Sul de Santa Catarina.
Animals were housed at 2272 1C under a 12 hours light/12 hours
dark cycle (lights on at 06:00) and with free access to food and
water. Animals were acclimatized to the laboratory for at least
1 hour before testing and were used only once throughout the
experiments. The number of animals and intensities of noxious
stimuli used were the minimum necessary to demonstrate the
consistent effects of drug treatments.
2.2. Extraction of vegetal material
The fruits of P. pubescens Benth were acquired in the medicinal
garden of the Florianopolis’ Health Pastoral, Santa Catarina, Brazil
and identiﬁed by Dr. Rafael Trevisan (Department of Botany,
Federal University of Santa Catarina, Floriano´polis, Brazil). The
dried fruits (with seed) of P. pubescens (100 g) were powdered and
submitted to maceration with alcohol cereals (1 L) at room
temperature. After 30 day, the extract was ﬁltered and the solvent
was evaporated under reduced pressure in a rotative evaporator
to yield a oleaginous extract of P. pubescens (OEPp) (20,716 g) as
previously described (Coelho et al., 2005).
2.3. Phytochemical analysis of the extract from P. pubescens
The oil was analyzed by chromatography-mass spectrometry
(GC–MS). The analysis was performed in a GC–MS QP5050
Shimazdu (70 eV) apparatus, using DB-5 column (30 m
0.25 mm0.25 mm) and helio carrier gas. The column tempera-
ture was programmed 60–280 1C (3 1C min) with isotherm 290 1C
to 5/ min and ﬂux of 1 mL/min. The data spectral were compared
to the literature. The separation of major compounds was by ﬂash
chromatography column eluted with 20% hexane:acetate. Andisolated compounds were subjected to spectrometry of 1H, 13C
NMR and GC/MS analyses.
2.4. Formalin test
Formalin-induced nociception was measured as previously
described (Hunskaar et al., 1985; Martins et al., 2011). Animals
were injected with 20 mL of a 2.5% formalin solution (0.92%
formaldehyde in saline) intraplantarly (i.pl.) in the ventral surface
of the right hindpaw. Animals were observed for 30 min; the time
between 0 and 5 min represented the neurogenic phase and the
time between 15 and 30 min represented the inﬂammatory
phase. Time spent licking the injected paw was recorded and
was indicative of nociception. To determine the effects of OEPp
administration on nociception, animals were treated with OEPp
(1–100 mg/kg, i.g.) 1 hour before formalin injection in the right
hindpaw. Control animals were treated with vehicle (5% tween 80
in saline, 10 mL/kg, i.g.) 1 hour before formalin injection. After the
formalin injection, animals were immediately placed in individual
glass cylinders (20 cm diameter). Antinociception was expressed
as a reduction of time that treated group spent licking the paw in
relationship to the control group.
The antiedematogenic effect of EOPp was assessed by measur-
ing the external diameter of the hind paw using a vernier caliper
(Starrett: 125MEB-6/150) after the assessment of licking caused
by formalin. Measurements were obtained from each group of
mice, and the edema difference for each animal was generated by
subtracting the diameter of the left hind paw (saline injection)
from the right hind paw (formalin solution).
2.5. Plantar incision surgery
The plantar incision surgery (PIS) was performed as previously
described (Pogatzki and Raja, 2003). Brieﬂy, mice were anesthe-
tized with 1%–2% isoﬂurane delivered via a nose cone. After sterile
preparation of the right hind paw, a 5 mm longitudinal incision
was made through skin and fascia of the plantar surface using a
number 11 scalpel blade. The incision started 2 mm from the
proximal edge of the heel and extended toward the toes. The
underlying muscle was elevated with curved forceps, leaving
the muscle origin and insertion intact. After wound homeostasis,
the skin was apposed with a 6.0 mm nylon mattress suture, and
the wound was covered with 10% povidone–iodine solution.
Control animals were anesthetized but no incision was made.
Animals were allowed to recover in their cages, and sutures were
removed on the second postoperative day.
2.6. Chronic post-ischemic pain
Chronic post-ischemic pain (CPIP) is an animal model of
CRPS-I developed using a 3 hours ischemia-reperfusion injury
of the rodent right hind paw. CPIP induction was performed as
described previously (Millecamps et al., 2010). CPIP mice were
generated following exposure to prolonged hind paw ischemia
and reperfusion (IR). Mice were anesthetized over a 3 hours
period with a bolus (7%, 0.6 mL/kg, i.p.) of chloral hydrate and
20% of the initial volume at the end of the ﬁrst and second hour.
After induction of anesthesia, an elastic O-ring for braces
(Ela´stico Ligadura 000–1237, Uniden) with 1.2 mm internal
diameter was placed around the mouse’s right hind limb just
proximal to the ankle joint. The O-rings were selected to provide
a tight-ﬁt that produced ischemia. They were left on the limb for
3 hours as initially described with larger O-rings. The O-ring was
always positioned at a point on the limb just proximal to the
medial malleolus and its application was standardized by sliding
it off the outside of a 100 mL pipette tip (that had 4 mm of the
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as far as possible. Sham mice received exactly the same treat-
ment except that the O-ring was cut so that it only loosely
surrounded the ankle and did not occlude blood ﬂow to the right
hind paw.2.7. Mechanical allodynia
The mechanical allodynia was measured as described pre-
viously (Bortalanza et al., 2002). Mice were acclimated in indivi-
dual clear boxes (9711 cm3) on an elevated wire mesh
(6 mm) platform (7040 cm) to allow access to the ventral
surface of the hind paws. The right hind paw was stimulated
with a constant pressure of 0.4 g von Frey ﬁlaments (VFF)
(Stoelting, Chicago, USA). The response frequency to 10 applica-
tions was taken as the nociceptive behavior. The results are
expressed as the percentage of withdrawal response. The day
before surgery, the animals were subjected for testing to char-
acterize the baseline response. Only animals that showed a
response rate around 20% were selected.
In postoperative pain (24 hours after surgery) or CPIP (2nd and
7th days after surgery) models we investigated the time course of
OEPp (0.1–100 mg/kg, i.g.) antinociceptive effect, the animals
were evaluated 1, 2 and 4 hours after treatment. Control animals
received a similar volume of vehicle (10 mL/kg, i.g.). To investi-
gate the effects of long-term treatment with OEPp (100 mg/kg,
i.g.), the treatment was repeated for 6 consecutive days (days 1st–
6th) after PIS.
In the model of CPIP, to investigate the effects of long-term
treatment OEPs (100 mg/kg) or vehicle were administered intra-
gastric to mice once a day for 5 consecutive days (from 7th to
11th day after IR). The treatment was interrupted and reinitiated
on 14th day after the IR and continued until the 15th day.
Mechanical allodynia was measured every day, always 1 hour
after OEPp (100 mg/kg, i.g.) treatment (postoperative pain and
CPIP models).2.8. Thermal hyperalgesia
To assess thermal hyperalgesia to cold and hot stimulus in
mice, the Cold/Hot Plate Analgesia Meter (Columbus Instruments,
USA) was used according to a minor modiﬁcation of the method
described by Bennett and Xie (1988). Mice were placed in clear
plastic chambers (7911 cm3) on an elevated surface. They
were acclimatized to the environment for 1 hour before testing.
To analyze cold thermal hyperalgesia mice were placed on the
cold plate (1071 1C) and to analyze heat thermal hyperalgesia
mice were placed in the hot plate (4871 1C). Mice were treated
with OEPp (100 mg/kg, i.g.) or vehicle (10 mL/kg, i.g.) 1 hour
beforehand. The nociception was evaluated by the right hindpaw
withdrawal latency. The cut-off latency for cold plate test was
120 seconds and for hot plate was 60 seconds. The nociceptive
behavior was tested 24 hours after PIS.2.9. Measurement of locomotor activity
To evaluate the effect of OEPp on spontaneous locomotor
activity, mice were submitted to the open ﬁeld test (Martins
et al., 2011). The open-ﬁeld apparatus consisted of a wooden box
measuring 406050 cm. The ﬂoor of the arena was divided
into 12 equal squares, and the number of squares crossed by the
animal with all paws was counted in a 6 min session. Mice weretreated with OEPp (1–100 mg/kg, i.g.) or vehicle (10 mL/kg, i.g.)
1 hour beforehand.
2.10. Statistical analysis
Data are presented as means7standard error of the
mean (S.E.M.). The ID50 value was determined from experiment
using nonlinear regression GraphPad software (GraphPad Soft-
ware, Inc., San Diego, CA). Formalin and open ﬁeld test was
performed by 1-way ANOVA followed by the Newman–Keuls’
test, when appropriate CPIP and postoperative pain testing
was compared using two-way analysis of variance (ANOVA) for
repeated measures, with Bonferroni’s multiple comparison as the
post-hoc test. P-values that were less than .05 were considered
signiﬁcant.3. Results
3.1. Phytochemical analysis of the extract from P. pubescens
The chemical analysis of the OEPp sample used in the present
investigations showed two distinct regions, in the sesquiterpene
(RT between 25 and 33 min) and diterpene (RT between 55 and
70 min) regions, representing seventeen compounds of the total
oil content (Fig. 1A). This work focused in a special kind of
diterpene compounds, the vouacapane, since the compound is
well described in the literature (Arriaga et al., 2000; Spindola
et al., 2010).
The GC–MS analysis (Fig. 1B and C) together with literature
data (Santos et al., 2010; Coelho et al., 2005; Arriaga et al., 2000;
Adams, 1995) identifed eight sesquiterpene compounds (Table 1),
three major sesquiterpene (E-carioﬁlene, g-muurolene and bici-
clogermacrene), and nine vouacapane diterpenes (Table 1), in
which four showed in major concentration (6a-acetoxyvouaca-
pane, 6a,7b-dimetoxivouacapan-17-ene, 6a-acetoxy,7b-hidroxy-
vouacapane and 6a,7b-diacetoxycouacapane). The majority
compounds were isolated by ﬂash chromatograph and subjected
to 1H NMR, 13C NMR and MS spectrometric analysis and compar-
ing with literature data (Arriaga et al., 2000; Spindola et al.,
2009; Coelho et al., 2005) which conﬁrmed the structure of majority
compounds sesquiterpenes 3 (E-carioﬁlene), 6 (g-muurolene), 7
(biciclogermacrene) and vouacapane diterpenes 12 (6a-acetoxy-
vouacapane), 15 (6a,7b-dimetoxivouacapan-17-ene), 16 (6a-acet-
oxy-7b-hidroxyvouacapane), 17 (6a,7b-diacetoxycouacapane).
3.2. Acute OEPp administration reduces formalin-induced
nociception
The results depicted in Fig. 2A and B show that OEPp (3–100 mg/
kg) administered by intra-gastric (i.g.) gavage caused signiﬁcant
inhibition of both neurogenic and inﬂammatory phases of formalin-
induced licking. The calculated mean ID50 value for the second
phase was 9.88 (9.42–10.35) mg/kg and the inhibitions observed
were 6375% for the ﬁrst phase and 6577% for the second phase
(100 mg/kg, i.g.). Furthermore, the OEPp (100 mg/kg, i.g.) also
produced antiedematogenic effect with reduction of 52711%
(Fig. 2C), when compared to the control group.
3.3. Acute and chronic OEPp administration reduces mechanical
allodynia after hind paw incision
The results of Fig. 3A show that OEPp (0.1–100 mg/kg)
administered by intra-gastric (i.g.) gavage caused a signiﬁcant
inhibition of plantar incision-induced allodynia when compared
to the control group. The effect was maintained by 2 hours after
Fig. 1. Chromatograms of total ions the compounds from the extract of P. pubescens species in region of the sesquiterpene (A), diterpene (B) and full chromatogram (C).
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observed inhibitions at the 2nd hour after treatment were 2771%
and 3579% for the doses of 10 and 100 mg/kg, respectively. Whenadministered chronically (once a day) for 6 day, OEPp (100 mg/kg,
i.g.) signiﬁcantly reduced the mechanical allodynia caused by
plantar incision (inhibition from 4771% to 6871%, Fig. 3B).
Table 1
Data of mass chromatogram-fragment of compounds present in oil.
Compound Fragment
1 105 (100), 204 (16), 189(5), 161 (95), 147 (5),133 (11), 119 (95), 91 (46), 81 (27), 69 (11), 55 (16), 41 (38)
2 93 (100), 189 (24), 175 (5), 161 (24), 147 (35), 133 (27), 121 (32), 105 (59), 81 (89), 79 (27), 67 (73), 53 (40), 41 (54)
3 41 (100), 204 (5), 189 (13), 175 (8), 161 (27), 147 (24), 135 (8), 133 (65), 119 (32), 105 (54), 93 (92), 79 (54), 69 (84), 55 (32), 53 (24).
4 93 (100), 204 (5), 161 (2,7), 133 (16), 121 (2,7), 107 (16), 105 (11), 80 (35), 79 (19), 67 (13), 65 (5), 55 (11), 53 (11), 41 (27)
5 41 (100), 204 (27), 189 (19), 176 (2,7), 161 (65), 147 (35), 133(54), 119 (49), 107 (57), 105 (76), 93 (57), 91 (95), 81 (51), 79 (62), 69 (51), 67 (54), 55 (40)
6 161 (100), 204 (16), 189 (2,7), 147 (5), 133 (19), 119 (35), 105 (68), 93 (27), 91 (54), 81 (38), 79 (35), 69 (13), 67 (16), 55 (19), 53 (11), 41 (38)
7 121 (100), 204 (13), 189 (11), 161 (27), 147 (8), 136 (19), 133 (8), 107 (51), 105 (38), 93 (81), 91 (43), 81 (27), 79 (40), 67 (27), 55 (19), 41 (46)
8 161 (100), 204 (43), 189 (19), 176 (2,7), 134 (51), 119 (57), 105 (57), 91 (38), 81 (24), 65 (8), 55 (13), 41 (27)
9 108 (100), 286 (40), 271 (11), 177 (11), 133 (8), 79 (13), 69 (11), 55 (13), 41 (19), 32 (8)
10 132 (100), 330 (3), 270 (38), 255 (13), 160 (11), 148 (24), 117 (43), 91 (30), 81 (27), 55 (30), 43 (59), 32 (27)
11 43 (100), 330 (19), 288 (5), 270 (19), 255 (57), 178 (46), 159 (27), 145 (24), 131 (35), 105 (81), 91 (57), 79 (54), 55 (51), 32 (32).
12 147 (100), 344 (5), 284 (13), 269 (5), 131 (13), 108 (11), 91 (5), 79 (8), 55 (8), 43 (16)
13 271 (100), 332 (3), 331 (16), 330 (78), 302 (46), 284 (11), 256 (8), 177 (49), 161 (13), 145 (27), 131 (73), 108 (89), 91 (59), 81 (59), 69 (73), 43 (59), 41 (89),
32 (73)
14 108 (100), 342 (24), 302 (30), 287 (59), 197 (27), 159 (19), 145 (40), 131 (27), 91 (19), 69 (40), 55 (35), 43 (59), 32 (59)
15 108 (100), 344 (2), 284 (11), 269 (22), 199 (11), 145 (22), 133 (24), 105 (22), 79 (19), 69 (19), 43 (40)
16 43 (100), 360 (32), 300 (65), 285 (22), 267 (13), 197 (27), 145 (92), 133 (65), 108 (89), 95 (32), 81 (40), 69 (49)
17 43 (100), 402 (11), 282 (89), 267 (13), 197 (84), 185 (13), 158 (30), 133 (54), 108 (30), 81 (16), 69 (22)
(1), a-copaene; (2), b-elemene; (3), E-carioﬁlene; (4), a-humulene; (5), alloaromandendrene; (6), g-muurolene; (7), biciclogermacrene; (8), d-cadinene; (9), vouacapane;
(10), 6a-hidroxyvouacapane-7,17b-lactone; (11), 18a-hidroxyvouacapan-b7,17-lactone; (12), 6a-acetoxyvouacapane; (13), 6a-hidroxyvouacapan-b17- oic acid;
(14), 6a-acetoxyvouacapan-17-ene; (15), 6a,7b-dimetoxivouacapan-17-ene; (16), 6a-acetoxy-7b-hidroxyvouacapane; (17), 6a,7b-diacetoxycouacapane.
Fig. 2. Oleaginous extract P. pubescens administered intra-gastric reduces formalin-induced licking (ﬁrst phase, panel A, and second phase, panel B) in mice and edema
formation (diameter of paw, panel C). Each column represents the mean of the values obtained in 8 animals and the vertical lines indicate the S.E.M. The closed columns
indicates the vehicle value (animals injected with vehicle) and the open columns correspond to animals treated with extract, the asterisks denote the signiﬁcance levels,
when compared with control group, (one-way ANOVA followed by Newman–Keuls’ test) nPo0.05 and nnnPo0.001.
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allodynia and thermal hyperalgesia after hind paw ischemia/
reperfusion
3.4.1. Mechanical allodynia
The results presented in Fig. 4 show that OEPp (0.1–100 mg/
kg) administered by i.g. gavage caused a signiﬁcant inhibition of
mechanical allodynia in CPIP mice, when compared to control
group (Fig. 4A 2nd day and Fig. 4B 7th day). We observed that on
the 2th or 7th days post-ischemia/reperfusion, OEPp produced
antiallodynic effect that was maintained for 3 hours after treat-
ment with the doses of 1, 10 and 100 mg/kg on the 2nd day after
surgery; and at a dose of 100 mg/kg, on the 7th day after surgery
(Fig. 4A 2nd day and Fig. 4B 7th day). The observed inhibitions at
the 3rd hour after treatment, on the 2nd day, were 3971, 4971
and 4571% for the doses of 1, 10 and 100 mg/kg, respectively.
Furthermore, on the 7th day, 3 h after treatment, the inhibition
was 3379% for the dose of 100 mg/kg.
In the long-term treatment, OEPp (100 mg/kg, i.g.) was admi-
nistered once a day for 5 day. The treatment signiﬁcantly reduced
mechanical allodynia (inhibition of 6171%; Fig. 4C), and the
assessments were always conducted 1 hour after treatment.
Moreover, when the treatment was interrupted, the mice imme-
diately exhibited a reestablishment of the mechanical allodynia.
On the 14th day, the treatment was reinitiated and a signiﬁcantinhibition of the mechanical allodynia was observed (inhibition of
5171%, Fig. 4C).
3.4.2. Thermal hyperalgesia
The plantar incision surgery induced a decreased of the paw
withdrawal latency during a thermal stimulus (heat and cold) in
comparison to non-injured mice (Fig. 5A and B, respectively).
Intra-gastric pretreatment with OEPp (100 mg/kg) reduced the
thermal hyperalgesia induced by the incision. Furthermore, the
latency to paw withdrawal was increased by 28 and 64%, for the
heat and cold assessments, respectively.
3.4.3. Locomotor activity
OEPp treatment (1–100 mg/kg, i.g., given 60 min beforehand),
did not alter mouse ambulation in the open ﬁeld test. The
crossing numbers after administration were 94.073.6,
91.578.7, 94.879.6 and 96.4711.4 for the control group and
the groups receiving 1, 10 or 100 mg/kg of OEPp, respectively
(data not shown).
4. Discussion
Sucupira seeds are commercially available in the Brazilian
medicinal plant market. The crude alcoholic extracts of this plant
Fig. 4. Oleaginous extract P. pubescens administered intra-gastric reduces pain in complex regional pain syndrome type-I animal model. Time-course of the antinociceptive
effect of OEPp (0.1–100 mg/kg., i.g.), on the mechanical allodynia (2nd day, panel A; 7th day, panel B). Chronic administration wit OEPp (100 mg/kg., i.g.) on the mechanical
allodynia (panel C). Each point represents the mean of the values obtained in 8 animals and the vertical lines indicate the S.E.M. The closed points indicates the vehicle
value (animals injected with vehicle) and the open points correspond to animals treated with extract, the asterisks denote the signiﬁcance levels, when compared with
control group or ### Po0.001 when compared with sham-operated group (Two-way ANOVA followed by Bonferroni’s test) nPo0.05, nnPo0.01 and nnnPo0.001.
B: baseline withdrawal threshold; CPIP: Chronic post-ischemic pain.
Fig. 3. Oleaginous extract P. pubescens administered orally decreases postoperative pain. Time-course of the antiallodynic effect of OEPp on the mechanical nociception
(panel A). Chronic administration with OEPp on the mechanical allodynia (panel B). Each point represents the mean of the values obtained in 8 animals and the vertical
lines indicate the S.E.M. The closed points indicates the vehicle value (animals injected with vehicle) and the open points correspond to animals treated with extract, the
asterisks denote the signiﬁcance levels, when compared with control group or ### Po0.001 when compared with sham-operated group (Two-way ANOVA followed by
Bonferroni’s test) nPo0.05 and nnnPo0.001. B: baseline withdrawal threshold; PIS: Plantar incision surgery.
C. Nucci et al. / Journal of Ethnopharmacology 143 (2012) 170–178 175are used in folk medicine as anti-inﬂammatory, analgesic and
anti-rheumatic preparations (Lorenzi, 1998; Pio Correa, 1975).
The present study conﬁrms and extends previous data from the
literature and demonstrates that systemic (oral) administration of
oleaginous extract of P. pubescens (OEPp) elicits a potent and
dose-dependent inhibition of the nociceptive behavioral response
in animal models of acute and chronic pain. The most relevant
results in the work are that (1) intra-gastric administration ofOEPp caused signiﬁcant inhibition against both phases of the pain
response to the intraplantar injection of formalin and edema
formation; (2) acute and chronic intra-gastric administration of
OEPp also reduced mechanical allodynia after incision or ische-
mia/reperfusion of hind paw, to our knowledge this is the ﬁrst
report of its kind in the literature; (3) OEPp increased the
response latency in the hot- and cold-plate tests after paw
incision and (4) the dose of OEPp that caused signiﬁcant
Fig. 5. Oleaginous extract P. pubescens decreases thermal hyperalgesia in postoperative pain animal model. Heat and cold hyperalgesia were evaluated 60 min after
treatment with OEPp (panel A and B, respectively) 24 h after incision of hind paw. Each point represents the mean of the values obtained in 8 animals and the vertical lines
indicate the S.E.M. The closed columns indicates the vehicle value (animals injected with vehicle) and the open columns correspond to animals treated with OEPp (100 mg/
kg., i.g.), the asterisks denote the signiﬁcance levels, when compared with control group or #Po0.05 and ###Po0.001 when compared with sham-operated group (one-
way ANOVA followed by Newman–Keuls’ test) nnnPo0.001. PIS: Plantar incision surgery.
C. Nucci et al. / Journal of Ethnopharmacology 143 (2012) 170–178176antiallodynic effect did not produce any statistically signiﬁcant
motor dysfunction or any detectable side-effect.
P. pubescens, popularly known in Brazil as ‘sucupira branca’,
has been widely used by domestic medicine as an anti-inﬂam-
matory (Coelho et al., 2005). Data in the literature has demon-
strated that the extract of P. emarginatus inhibits both neurogenic
and inﬂammatory phases observed in the formalin test (Galceran
et al., 2011). Corroborating these data, we also demonstrated that
OEPp caused signiﬁcant and dose-related antinociception when
administered orally against both neurogenic (early phase) and
inﬂammatory (late phase) pain responses caused by formalin
injection. Furthermore, OEPp also attenuated partially but sig-
niﬁcantly the edema formation associated with the late phase of
the formalin response. It has been demonstrated that kinins,
prostanoids and serotonin, but not tachykinin, play an important
modulatory role in controlling formalin induced edema formation
(Correˆa et al., 1996; Santos and Calixto, 1997).
Phytochemical studies of the Pterodon genus have shown the
presence of alkaloids, isoﬂavones and diterpenes. In this regard, it
has been demonstrated that furanditerpenes identiﬁed from
Pterodon fruits (Mahjan and Monteiro, 1973; Spindola et al.,
2009) contribute to the anti-inﬂammatory and antinociceptive
properties of P. pubescens seed oil (Nunan et al., 1982; Coelho
et al., 2005). Furthermore, diterpenes 6a-hydroxyvouacapan-7b-
17b-lactone and 6a,7b-dihydroxyvouacapan-17b-oate methyl
ester found in P. emarginatus and P. polygalaeﬂorus seeds also
appears to contribute with the anti-inﬂammatory activity of these
species (Nunan et al., 1982).
Another interesting data of the present study is the demon-
stration, for the ﬁrst time, that acute or prolonged treatment of
mice with OEPp was able to reduce, in a great manner, mechan-
ical allodynia in a mouse postoperative pain model. Moreover, the
antiallodynic effect of OEPp lasted for up to 2 h when analyzed in
the mechanical allodynia caused by paw incision. Postoperative
pain in humans can be mimicked by paw incision in rats (Brennan
et al., 1996). Thus, the plantar incision model may also be useful
for predicting postoperative analgesic effects of investigational
agents.
Several approaches have been used to reduce postoperative
pain, including administration of systemic opioids and non-
steroidal anti-inﬂammatory drugs, epidural or spinal infusion of
local anesthetics, and peripheral nerve block. It has been sug-
gested that postoperative pain produces a unique pharmacology
of analgesia compared with other sustained pain models. For
example, it was reported that reuptake inhibition of NA and 5-HT(milnacipran) in the spinal cord inhibits postoperative pain
(Obata et al., 2001). In agreement with these results, previous
studies using the acetic acid test have shown that 6a,7b-dihy-
droxyvouacapan-17b-oate methyl ester (crude alcoholic extracts
obtained from P. pubescens Benth) presented a signiﬁcant loss of
activity after p-chlorophenylalanine methyl ester hydrochloride
(PCPA, 5-HT synthesis inhibitor) treatment, suggesting that the
mechanisms of action could be related to either the synthesis or
release of serotonin (Spindola et al., 2011).
Neurotransmitters released by noxious stimuli may contribute
to the enhanced excitability following surgical injury. Of late,
particular attention has been paid to the action of excitatory
amino acids (EAAs) (Coderre and Melzack, 1992). Several ﬁndings
were derived from experiments conducted using the post-opera-
tive model of pain and spinal EAAs receptor antagonists (Zahn
et al., 1998; Zahn and Brennan, 1998). The intrathecal non-NMDA
receptor antagonist returned the withdrawal threshold nearly to
pre-incision levels. Furthermore, the activation of spinal non-
NMDA, AMPA-kainate receptors were found to mediate guarding
behavior and the reduced withdrawal threshold that develops
after an incision (Zahn et al., 1998). In surgery, after tissue injury
and inﬂammation, nociceptors are sensitized in such a way that a
slight stimulation becomes painful. In postoperative pain, the
sensitization of Ad and C ﬁbers occurs at the same mechanical
stimuli intensity. It has been suggested that TRPV1 is important
for generation of thermal hyperalgesia after incision (Pogatzki-
Zahn et al., 2005). In agreement with these reports, it has been
demonstrated that geranylgeraniol and 6a,7b-dihydroxyvouaca-
pan-17b-oate methyl ester isolated from P. pubescens Benth
produces antinociceptive activity when evaluated in the capsaicin
and glutamate animal experimental models (Spindola et al.,
2010).
Complex Regional Pain Syndrome Type I (CRPS I) is a severe,
disabling, and painful disease which may occur in an extremity
after a trauma or injury. Clinical features include spontaneous and
stimulus-evoked pain, edema, vasomotor and sudomotor distur-
bances, motor dysfunction, and trophic changes, without evi-
dence of peripheral nerve injury (Mersky and Bogduk, 1994;
Stanton-Hicks et al., 1995). The experimental model of CRPS-I
produced by IR of paw in rat or mice are able to mimic important
symptoms observed in patients with peripheral neuropathy and
are employed in behavioral research (Millecamps et al., 2010;
Coderre et al., 2004). Furthermore, it has been demonstrated that
only high doses of morphine, dexamethasone and pregabalin
partially reduced mechanical allodynia 2 day post-ischemia/
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amitriptyline) were not effective. In seven days post-ischemia/
reperfusion only the highest dose of pregabalin reduced mechan-
ical allodynia (Millecamps and Coderre, 2008).
Also of interest are the results showing that acute or prolonged
systemic (oral) treatments of animals with OEPp are effective in
preventing the mechanical allodynia induced by ischemia/reper-
fusion (IR) of the hind paw. Responses of rats or mice with chronic
post-ischemia pain to classical pharmacological treatments exhi-
bit a proﬁle very similar to the proﬁle in human complex regional
pain syndrome-I patients, with an early period sensitive to anti-
inﬂammatory drugs and morphine, and a later period similar to
neuropathic pain patients, in which a resistance develops to these
treatments. To assess the clinical potential of OEPp as an anti-
inﬂammatory and -neuropathic drug, we treated mice with OEPp
on the 2nd and 7th days after IR. OEPp was effective on both days,
which similar to the effectiveness of others drugs, i.e. pregabalin,
with effects in various pain conditions. Moreover, the anti-
allodynic action of OEPp lasted for up to 3 h.
Interestingly, the anti-allodynic response caused by OEPp
produced not accumulative effect. This conclusion derives from
data showing that (1) the withdrawal of OEPp was followed by
complete return to baseline mechanical allodynia, and (2) a new
intra-gastric treatment with OEPp, once a day, produced very
similar and pronounced anti-allodynic effects. To our knowledge
this is the ﬁrst report of its kind in the literature.5. Conclusions
In summary, the results of the present study demonstrate for
the ﬁrst time that OEPp reduced mechanical allodynia in post-
operative pain and complex regional pain syndrome type-I animal
models and increased the latency response in hot- and cold-plate
tests after paw incision (postoperative pain). In addition, the
present work conﬁrms and extends previous data from the
literature showing that systemic administration of OEPp caused
signiﬁcant inhibition against both phases of the pain response to
the intraplantar injection of formalin and edema formation. This
could provide a rationale for the use of this plant to treat pain
disorders in folk medicine.Conﬂict of interest
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